Abcellera receives authorization from health canada to initiate the phase 1 clinical trial of abcl635 for vasomotor symptoms due to menopause

Vancouver, british columbia--(business wire)---- $abcl--abcellera receives authorization from health canada to initiate the phase 1 clinical trial of abcl635 for vasomotor symptoms due to menopause.

ABCL Ratings Summary

ABCL Quant Ranking